If you have taken CYLERT (pemoline) and you have suffered from serious side effects you may be entitled to compensation.

Pemoline ( Cylert ) Warnings

Public Citizen Petitions FDA to Take Pemoline Off the Market

CYLERT (pemoline) is a central nervous system stimulant, used as a prescription therapy for Attention Deficit Hyperactivity Disorder (ADHD). ADHD is the most common behavioral disorder in children, and is typically characterized by a short attention span, hyperactivity, impulsivity, and moderate to severe distractibility. Some researchers estimate that up to 10% of school-aged children are affected.

Cylert was approved by the FDA in 1975. In the 30 years Cylert (Generic: Pemoline) has been on the market the FDA has twice had to strengthen the warning labels of the medication. While both Britain and Canada have banned the pharmaceutical drug, the FDA has instead encouraged Abbott Laboratories to perform additional studies.

Reports given to the Food and Drug Administration show that at least 193 patients have suffered serious consequences from the drug, said Dr. Peter Lurie, deputy director of Public Citizen. "This is an outmoded drug," he said, "and there is no reason for it to be still on the market.

In 1996 Abbott Laboratories sent an 'Important Drug Warning' to doctors regarding the dangerous side effects of Pemoline (Cylert). In this letter Abbott Laboratories disclosed ten deaths of acute liver failure in children (U.S.), with additional reports worldwide.

A new 'boxed warning' label for the prescription drug was announced. This warning included Abbott Laboratories' recommendation that "Because of its association with life threatening hepatic failure, CYLERT should not ordinarily be considered as first line drug therapy for ADHD..."

Despite the dangerous side effects, and the serious concerns from both the FDA and Abbott Laboratories, Pemoline ( Cylert ) continues to be on the market and was prescribed to 117,000 patients last year.

Please consult your physician before discontinuing any medication.

We believe that drug companies who place profit above people must be held accountable for their negligence and the damage they cause to innocent victim’s lives.

At Brown & Crouppen our experienced team of pharmaceutical lawyers provide tough, aggressive representation for victims and their families. When you choose us to handle your pharmaceutical negligence lawsuit, our entire team becomes fully committed to your cause. We’ll find answers, hold negligent companies responsible and get you the compensation you deserve.

Brown & Crouppen can help you make informed decisions about your legal rights, so please call Brown & Crouppen at Toll Free: 866-991-4700 for your free legal consultation or save time with our online Contact Form.

Related Pemoline News Links

Public Citizen Petitions FDA to Take Pemoline Off the Market (03/24/2005)
WASHINGTON, D.C. - Public Citizen today petitioned the U.S. Food and Drug Administration (FDA) to immediately remove pemoline (Cylert), a central nervous system stimulant used in the treatment of attention deficit hyperactivity disorder (ADHD), from the market because it is known to have caused at least 21 cases of liver failure, including 13 resulting in liver transplantation or death.

Pemoline Alert > Full Public Citizen Petition

FDA Pemoline ( Cylert ) Prescription Drug Information - including full 'box warning'

Call Brown & Crouppen at Toll-Free: 866-991-4700 for your free
legal consultation or save time with our online Contact Form.

Toll-Free: 866-991-4700